Images
Participants
Contact
El Mundo newspaper has published an article on a study by the University of Basel (Switzerland) that has found a way to separate the tumour cells that circulate in blood in groups and to prevent them from forming metastases. In this regard, they include the opinion of Roger Gomis, ICREA researcher at IRB Barcelona: "(This study) allows us to understand how to handle the aggregated cells that initiate the tumour, but now we need more effective and clinically optimal compounds. It is another step in a very fertile field such as the cells in circulation, but we must be realistic in terms of expectations. There is a gulf between what we see in the laboratory and what can be done with patients later on. "
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
